Abstract
The use of traditional herbal remedies has been a common practice for centuries across different cultures to treat various ailments. In Palestine, traditional herbal medicines are widely used, but their efficacy and safety have not been thoroughly investigated. Therefore, the purpose of this study was to assess the biological activity and toxicity of two traditional herbal blends often used to treat obesity in the West Bank region of Palestine. Two herbal blends with a total of eight plants were chosen based on their historic use and availability. The plant aqueous extracts were evaluated for their antioxidant, anti-fibrotic, anti-obesity, anti-diabetic, and cytotoxic activities. The results showed that these blends have potent antifibrotic, antioxidant, and anticancer activities. While their activities on α-amylase and lipase enzymes (main targets) showed moderate activities. Therefore, our results showed that Herbal Blend 2 was more potent than Herbal Blend 1 on all investigated targets. Herbal Blend 2 showed significant activities as an antioxidant, antifibrotic, and anticancer activities with IC50 values of 68.16 ± 2.45, 33.97 ± 1.14, and 52.53 ± 0.78 µg/mL against DPPH, LX-2, and MCF-7 cell lines, respectively. While it is IC50 values on α-amylase and lipase enzymes were 243.73 ± 1.57 and 1358.39 ± 2.04 µg/mL, respectively. However, the use of anti-cancer plants can be challenging due to their cytotoxic effects on the body. We urge individuals to exercise caution when using natural remedies and to seek medical advice before incorporating them into their health regimens. This study provides valuable insight into the potential health benefits of traditional herbal remedies and emphasizes the importance of responsible usage.
Similar content being viewed by others
Introduction
The West Bank of Palestine is home to a rich history of traditional herbal remedies used for centuries to treat various ailments. Despite their widespread use, these remedies have not been thoroughly evaluated for their safety and efficacy. Biological evaluation of traditional herbal remedies is essential to determine their potential as sources of novel therapeutic agents1,2. Traditional herbal remedies have been utilized for centuries to address various conditions such as obesity, diabetes mellitus, liver fibrosis, and cancer. They are believed to offer several advantages over modern medicine3.
Obesity is a major health concern globally, and the use of herbal supplements is gaining increasing popularity as a complementary therapy. Several herbal supplements, such as green tea, cinnamon, and turmeric have been found to have anti-obesity effects through various mechanisms, including reducing appetite, increasing energy expenditure, and enhancing lipid metabolism4,5.
Diabetes mellitus (DM) is a chronic metabolic condition affecting millions of people throughout the world6,7. The use of herbal supplements as an adjunct to conventional therapy has gained popularity due to their potential antidiabetic effects and fewer side effects. Some herbs, such as ginseng, fenugreek, and bitter melon have been found to have hypoglycemic effects through various mechanisms, including enhancing insulin secretion and sensitivity, and reducing glucose8,9.
Liver fibrosis is a progressive disease that can lead to liver cirrhosis and liver failure. Several chemicals and plant extracts have been shown to have anti-fibrotic effects on LX-2 cell lines. Some of these include; Curcumin, an extract from turmeric, which has been shown to have anti-fibrotic effects on LX-2 cells. Epigallocatechin gallate (EGCG), a compound found in green tea, has been shown to inhibit LX-2 cell proliferation and fibrosis. Quercetin, a natural flavonoid found in fruits and vegetables, has been shown to have antifibrotic effects on LX-2 cells by reducing oxidative stress and inflammation. Resveratrol, a compound found in red wine and grapes, has been shown to inhibit LX-2 cell proliferation and fibrosis10,11.
Oxidative stress is a major contributor to the development of several chronic diseases. Herbal supplements have been found to have potent antioxidant effects that can reduce oxidative stress and prevent the development of various diseases. Some herbs such as turmeric, ginger, and garlic have been found to have potent antioxidant effects through various mechanisms such as scavenging free radicals, enhancing endogenous antioxidant enzymes, and reducing oxidative damage to cellular components12,13.
Cancer stands as a significant contributor to both illness and death in Palestine, where the predominant type among males is lung cancer, and among females is breast cancer. The complexity of cancer manifests through diverse underlying mechanisms14. The use of herbal remedies as complementary therapy for cancer has gained popularity due to their potential anticancer effects. Several herbs such as green tea, ginger, and garlic have been found to have potential anticancer effects through various mechanisms such as inducing apoptosis, inhibiting angiogenesis, and reducing oxidative stress15,16.
The eight different medicinal plants include Camellia sinensis L. Kuntze, Zingiber officinale Roscoe, Cuminum cyminum L, Anthemis cotula L., Cinnamomum verum J. Presl, Natural Apple (Malus sylvestris Mill.) cider vinegar, Curcuma longa L, Allium sativum L., and Piper nigrum L. have biological activities on various biological targets as listed in Table 1.
Our decision to formulate a polyherbal Blend stems from the longstanding traditional use of such blends in our local market for addressing obesity-related concerns. These traditional formulations often passed down through generations, have garnered popularity due to anecdotal evidence suggesting their efficacy in managing obesity. However, we recognize that relying solely on historical usage is not sufficient in the context of modern scientific research. As reported, herbal supplements have shown promising effects in the management of obesity, DM, liver fibrosis, oxidative stress, and cancer. Therefore, the current work aims to evaluate two common traditional herbal blends in the West Bank of Palestine, which are consumed by people for obesity, and also assess their effects on different biological targets.
Material and methods
Plant collection and extraction
The Herbal blends 1 and 2 were taken in November 2021 from a Palestinian apothecary in the West Bank. The plants were identified by a pharmacognosist Prof. Dr. Nidal Jaradat and voucher specimens were deposited at the Natural Products Laboratory of the Faculty of Medicine and Health Sciences at An-Najah National University and kept under the herbarium voucher specimen number: Pharm-PCT-178, Pharm-PCT-2704, Pharm-PCT-2706, Pharm-PCT 2707, Pharm-PCT-2709, Pharm-PCT-2724, Pharm-PCT-2776, Pharm-PCT2790 as mentioned before in Table 1. All methods were carried out in accordance with applicable institutional, national, and international guidelines and legislation. The plant portions were stored in the shade at a regulated humidity (55 ± 5 RH) and temperature (25 ± 2 °C). Each herbal Blend was mixed in an equivalent ratio of each plant and Herbal Blend 1 included C. sinensis, Z. officinale, C. cyminum, A. cotula, C. verum, and natural vinegar. While Herbal Blend 2 included C. verum, C. longa, A. sativum, and P. nigrum. All of these plants extracts showed biological activities on various biological targets as listed in Table 1.
Instrumentation
A Spectrophotometer-UV/Visible (Jenway® 7135, Staffordshire, UK), filter papers (Whitman No. 1, Washington, USA), Shaker device (Memmert 531-25-1, Stockholm, Germany), rotavap apparatus (Heidolph-VV 2000, Schwabach, Germany), grinder (Aero Plus 500 W Mixer Grinder, I01, Wan Chai, China), electronic-balance (Radwag, AS 220/c/2, Toruńska, Poland) and Cryo-Desiccator (Mill-rock technology, BT85, Kingston, USA) were used.
Chemicals
Loba Chemie (Mumbai, India) provided acetone, sodium hydroxide, n-hexane, and methanol, while Alfa Agar (Binfeld, UK) provided Ninhydrin solution, Benedict’s, and Millon’s reagents. Alfa Aesar (Lancaster, UK) also provided iodine solution, sulfuric acid, and Molisch’s reagent. Sigma-Aldrich (Steinheim, Germany) provided the Folin-Ciocalteu’s reagent, hydrochloric acid, aluminum chloride, potassium acetate, chloroform, and 2,2-diphenyl-1-picrylhydrazyl (DPPH). Riedel-De-Haen (Teningen, Germany) provided magnesium ribbon, acetic acid, ferric chloride, and dimethyl sulfoxide (DMSO). Trolox ((s)-(-)-6-hydroxy-2,5,7,8-tetramethychroman-2-carboxylic acid) and quercetin were also obtained from Sigma-Aldrich (Sborg, Denmark). α-amylase, on the other hand, was brought in from Sigma (Mumbai, India). Sigma (St. Louis, USA) provided the DNSA (3,5-dinitro salicylic acid) reagent, Acarbose, p-nitrophenyl butyrate, Orlistat, tris–HCl buffer, and Porcine pancreatic lipase type II.
The water solvent fractionation method
Water is commonly used as a solvent in traditional herbal medicine due to its availability, non-toxicity, and ability to extract a wide range of compounds. It is also considered to be more representative of the traditional method of preparing herbal remedies36. The powdered substance of the two herbal blends was fractionated progressively by adding water (polar-protic solvents): Approximately 50 g of each Blend was steeped in 500 mL of water separately, and the fraction was shaken for 72 h at room temperature at 100 rounds/min. After that, it was refrigerated for 6 days. A Cryo-Desiccator was used to lyophilize the aqueous fraction. Finally, until future usage, all crude plant fractions were kept in the refrigerator at 4 °C.
Antioxidant
Activity For the evaluation of Herbal Blend fractions and Trolox (positive control), a concentration of 1 mg/mL in methanol was first produced from the Herbal blends. The generated solution was used to make concentrations of 5, 7, 10, 20, 30, 50, 80, and 100 µg/mL. The DPPH (2,2-diphenyl-1-picrylhydrazyl) reagent was then diluted in 0.002% w/v methanol and combined with the previously prepared working concentrations in a 1:1:1 ratio. The pure methanol solution served as a control. All of the solutions were incubated in a dark environment at room temperature for 30 min. The absorbance readings were then calculated using a UV–visible spectrophotometer with a wavelength of 517 nm. The percentage of antioxidant potential of each plant fraction and Trolox was calculated using the following formula:
AC is the absorbance of the control; AS is the absorbance of the tested samples. Using BioDataFit edition 1.0218, the antioxidant half-maximal inhibitory concentration (IC50) of each Herbal Blends was computed37,38.
Porcine pancreatic lipase inhibition assay
The anti-lipase assay was carried out following the findings of39 with slight modifications. In brief, a stock solution was generated by combining 1 mg/mL of each Herbal blend’s component with 10% dimethyl sulfoxide, from which concentrations of 50, 70, 500, 700, 1000, and 1500 µg/mL were prepared. A pancreatic lipase stock solution of 1 mg/mL was also combined with a Tris–HCl buffer solution. 20.90 mg of p-nitrophenyl butyrate was suspended in 2 mL of acetonitrile to make a stock solution. Then, 0.2 mL of plant fraction was mixed with 0.1 mL of porcine pancreatic lipase enzyme (1 mg/mL). The resulting herbal blends were then diluted to 1 mL with a Tri-HCl solution and stored at 37 °C for 15 min. Following that, each working Herbal Blend received 0.1 mL of p-nitrophenyl butyrate. These herbal mixes were incubated at 37 °C for 30 min. The hydrolysis of p-nitrophenolate to p-nitrophenol at 405 nm was calculated using a UV/visible spectrophotometer to assess pancreatic lipase activity. Furthermore, all of the Herbal mixes investigated were tested in triplicate.
α-amylase inhibitory assay
This process was conducted using a modified strategy. A 200 µL aliquot of each Herbal blends portion at 50, 70, 500, 700, 1000 and 1500 µg/mL concentrations was placed in a test tube with 200 µL of 0.02 M sodium phosphate buffer (pH 6.9) containing-amylase solution (2 units/mL). After 10 min at 25 °C, 200 µL of 1% starch solution mixed with 0.02 M sodium phosphate buffer solution (pH 6.9) was added at scheduled intervals and held for 10 min at 25 °C. The reaction was halted by the addition of 200 µl of DNSA.
These tubes were then placed in boiling water for 5 min before being cooled to room temperature. The herbal blends were then diluted with 5 mL of distilled water, and the absorbance at 540 nm was calculated using a UV–visible spectrophotometer. The same process was used to make a control herbal mix, but the plant fraction was replaced with distilled water. Using the following equation, the α-amylase inhibitory activity was determined as a percentage of inhibition: The amounts of plant components required to inhibit lipase enzyme activity by 50% (IC50) were calculated graphically. The same procedure was followed for the positive control of α-amylase inhibitory activity, Acarbose40,41.
Cell culture and cytotoxicity assay
The liver (Hep3B), breast (MCF-7), and human cervical (HeLa) tumor cell lines were grown separately in RPMI-1640 media (Sigma, Norwich, UK), which was supplemented with 1% l-glutamine (Sigma, London, UK), 1% penicillin/streptomycin antibiotics (BI, New Delhi, India), and 10% fetal bovine serum. Cancer cells were cultured in a humidified environment with 5% CO2 at 37 °C. In a 96-well plate, cells were planted at 2.6 × 104 cells/well. Cancer cells were cultured for 24 h with various concentrations (10, 50, 100, 250,100, 500, 2000, and 4000 µg/mL) of both herbal blends after 48 h. Cell viability was determined using the CellTilter 96® Aqueous One Solution Cell Proliferation (MTS) Assay (Promega Corporation, Madison, WI, USA) according to the manufacturer’s instructions. After the treatment, 20 µL of MTS solution per 100 µL of the medium was added to each well, and the well herbal blends were incubated at 37 °C for 2 h. At 490 nm, the absorbance was measured42,43.
Statistical analysis
The antioxidant, anti-lipase, anti-α-amylase, cytotoxic, and anti-fibrotic activities of the eight plant fractions tested were all given as mean SD standard deviation; the result was judged significant when the p-value < 0.05, as well as the p-values were calculated by using t-test function accordingly.
Result and discussion
The increasing use of traditional medicinal herbs has raised concerns about potential side effects and misapplication. Herbal products have been linked to a variety of negative side effects, including life-threatening conditions and serious injuries. Some of the difficulties in monitoring the safety of herbal remedies stem from the lack of mandatory safety evaluations before marketing, as well as the lack of quality standards regulations, and effective manufacturing practices in many countries44,45. Therefore, our study focused on the biological evaluation of two traditional herbal remedies containing eight herbal plants commonly used in traditional Palestinian medicine in the West Bank of Palestine and evaluate their anti-obesity, antidiabetic, antifibrotic, antioxidant, and anti-cancer effects.
The anti-oxidant activities of the evaluated Herbal blends were evaluated using the DPPH assay, and the results are displayed in Fig. 1. Herbal Blend 1 exhibited an IC50 value of 68.16 ± 2.45 µg/mL, while Herbal Blend 2 showed an IC50 value of 33.97 ± 1.14 µg/mL, compared to a positive control (Trolox) with an IC50 of 7.72 ± 1.05 µg/mL, as indicated in Table 2.
It was found that Herbal Blend 2 had a more potent antioxidant activity compared to Herbal Blend 1. The higher antioxidant activity of Herbal Blend 2 can be attributed to the presence of C. longa, A. sativum, and P. nigrum. In fact, C. longa is known to contain curcumin, which has been extensively studied for its potential antioxidant properties46. Similarly, A. sativum contains sulfur-containing compounds that also possess antioxidant properties. A study published in the Journal of Agricultural and Food Chemistry showed that garlic extracts have high antioxidant activity, as measured by the ORAC (Oxygen Radical Absorbance Capacity) assay47. Besides, an investigation established by Nahak and Sahu found that P. nigrum fruits exhibited remarkable DPPH free radicals scavenging ability at different concentrations48. Moreover, P. nigrum enhances the bioavailability of curcumin, thereby increasing the antioxidant potential of Herbal Blend 2. Although Herbal Blend 1 ingredients may also have some antioxidant potential, they may not be as potent as the combination of C. longa, A. sativum, and P. nigrum found in Herbal Blend 2.
The percentage of inhibition was measured for the Herbal blends at different concentrations, and the results are illustrated in Fig. 1. Herbal Blend 2 showed a significantly higher percentage of inhibition than Herbal Blend 1, and in some concentrations, it even surpassed the control (Trolox). For instance, at a concentration of 50 µg/mL, Herbal Blend 2 exhibited a percentage of inhibition of 68%, while Trolox showed 61%.
Herbal remedies have been used for centuries in traditional medicine for their anticancer and cytotoxic effects. These effects are attributed to the presence of various active compounds in plants, such as triterpene saponins, flavonoids, and phenolic compounds, which have been shown to inhibit cancer cell growth, induce apoptosis, and cause DNA damage49.
The anti-cancer activities of the tested Herbal blends were evaluated using the MTS assay, and the results showed that Herbal Blend 2 had potent anticancer activities against liver cancer and breast cancer compared to Herbal Blend 1, which also exhibited anticancer activities by inducing apoptosis in liver and breast cancer cells. The percentage of cell viability was measured at different concentrations for the Herbal blends, as shown in Fig. 2.
Based on the results of the biological evaluation, it was found that Herbal Blend 2 had a more potent anticancer activity compared to Herbal Blend 1. One possible reason for this difference in activity could be attributed to the presence of C. longa and A. sativum in Herbal Blend 2. C. longa contain curcumin, which has been extensively studied for its anticancer properties, Curcumin, employed in Ayurvedic medicine for its anti-inflammatory properties, has been reported to synergistically inhibit tumor cell growth and induce apoptosis50. Similarly, A. sativum contains organosulfur compounds including allicin, which have also been shown to possess anticancer properties51. Piper nigrum, which is present in both Herbal blends, is known to enhance the bioavailability of curcumin, potentially increasing its activity52. Additionally, previous studies explored the anticancer activity of P. nigrum fruits in both in vitro and in vivo breast cancer models which showed that the treatments with the plant extracts induced intracellular oxidative stress, which was considered the main component responsible for its cytotoxic effects in cancer cells53. In contrast, While these ingredients in Herbal Blend 1 may also possess some medicinal properties, they may not have the same level of anticancer activity as C. longa. and A. sativum found in Herbal Blend 2.
For Hep3B cancer cell lines, the IC50 of Herbal Blend 1 was 148.37 ± 2.45 µg/mL, while the IC50 of Herbal Blend 2 was 71.74 ± 1.77 µg/mL, compared to a positive control (DOX) with an IC50 of 1.21 ± 1.0 µg/mL, as shown in Table 2. Similarly, for MCF-7 cells, the IC50 of Herbal Blend 1 was 127.10 ± 2.08 µg/mL, while the IC50 of Herbal Blend 2 was 52.53 ± 0.78 µg/mL, compared to a positive control (DOX) with an IC50 of less than 1, as shown in Table 2. In addition, for HeLa cells, the IC50 of Herbal Blend 1 was 258.06 ± 1.07 µg/mL, while the IC50 of Herbal Blend 2 was 164.89 µg/mL, compared to a positive control (DOX) with an IC50 of 1.55 µg/mL, as presented in Table 2. These results indicate that Herbal Blend 2 has a stronger anti-cancer activity against liver cancer and breast cancer cells compared to Herbal Blend 1.
C. verum commonly known as Cinnamon, exhibits anti-cancer, antioxidant, anti-lipid, and anti-fibrotic properties17,54 It demonstrates anticancer effects against various cancer cell types, including breast cancer, through apoptosis induction and angiogenesis suppression. This extends to its efficacy against lung and colon cancer cells55,56. C. longa, or Turmeric, is recognized for its potent anti-cancer properties, effectively inhibiting the growth of various cancer cells such as those in breast, prostate, and colon cancers57,58,59. Additionally, C. longa displays significant antioxidant activity, contributing to the prevention of disorders associated with oxidative stress, including cardiovascular diseases and cancer57,60. The herb’s anti-lipid properties are notable, demonstrated by its ability to reduce blood glucose and lipid levels in diabetic mice. Furthermore, Curcuma longa showcases anti-fibrotic properties, suggesting potential benefits in preventing and treating fibrotic conditions like liver fibrosis20,21,61.
The anti-fibrotic activity of the tested Herbal blends was also evaluated, and it was found that Herbal Blend 2 exhibited more potent anti-fibrotic activity compared to Herbal Blend 1. The IC50 values for Herbal Blend 2 and Herbal Blend 1 in the anti-cancer assay were 24.36 ± 0.54 and 83.25 ± 2.45 µg/mL, respectively, while the control drug DOX showed an IC50 of < 1, as shown in Table 2. These results suggest that the tested Herbal blends may have potential therapeutic applications not only for fibrotic conditions but also for cancer treatment due to their multi-faceted activities. The findings of this study provide a basis for further research and development of these Herbal blends as potential anti-fibrotic, anti-cancer, and antioxidant agents.
Herbal Blend 2 had a more potent antifibrotic activity compared to Herbal Blend 1. The higher antifibrotic activity of Herbal Blend 2 could be due to the presence of C. longa and A. sativum in the Herbal blend. Curcumin, present in C. longa has been reported to have antifibrotic properties by inhibiting fibrosis-promoting factors62. Additionally, A. sativum contains sulfur-containing compounds that possess antifibrotic properties63. Therefore, the combination of C. longa and A. sativum in Herbal Blend 2 may be responsible for its higher antifibrotic activity.
When considering all of these activities together, it is evident that Herbal Blend 2 has the potential to provide multiple benefits for individuals with liver cancer. The anti-cancer activity of Herbal Blend 2 against Hep3B cells, combined with its anti-fibrotic activity, may help to prevent the progression of liver fibrosis, a common complication of liver cancer. Furthermore, the antioxidant activity of Herbal Blend 2 may help to protect liver cells from oxidative stress, which is known to contribute to the development and progression of liver cancer. Therefore, the multi-faceted benefits of Herbal Blend 2 make it a promising candidate for further investigation and development as a potential therapeutic agent for liver cancer.
Figure 3 displays the percentage of LX-2 cells inhibition at various concentrations for both Herbal Blend 1 and Herbal Blend 2, demonstrating promising results. The inhibition percentages for the Herbal blends were compared with those of 5FU and DOX. At a concentration of 80 µg/mL, Herbal Blend 2 exhibited an inhibition percentage of 68%, while Herbal Blend 1 displayed a percentage of 50%. In contrast, the inhibition percentages of 5-Fu and DOX were 72% and 75%, respectively. Moreover, at a concentration of 250 µg/mL, Herbal Blend 2 demonstrated a percentage of 77%, which was almost equivalent to the percentage of Herbal Blend 1 (77%). However, the LX-2 cells inhibition percentages of 5-Fu and DOX were 95% and 75%, respectively. These results indicate that both Herbal blends have significant inhibitory effects on LX-2 cancer cells and suggest that they could be effective alternatives to traditional chemotherapy drugs.
The anti-diabetic and anti-obesity potential of the tested Herbal blends was evaluated by examining their effects on porcine pancreatic α-amylase and lipase enzymes. The results showed that Herbal Blend 2 exhibited more potent anti-amylase activity compared to Herbal Blend 1, with IC50 doses of 243.73 ± 1.57 and 468.98 ± 2.44 µg/mL, respectively. In contrast, the control drug Acarbose displayed an IC50 value of 6.42 ± 1.02 µg/mL, indicating that both Herbal blends have moderate anti-amylase effects. However, there was a negligible effect on lipase activity for both Herbal blends, as Herbal Blend 2 and Herbal Blend 1 exhibited IC50 values of 1358.39 ± 2.04 and 1466.85 ± 3.54 µg/mL, respectively, whereas the control drug Orlistat had an IC50 value of 5.44 µg/mL, as shown in Table 2. These findings suggest that the evaluated Herbal blends could be used as natural treatments for diabetes and obesity due to their significant anti-amylase activity with caution because of their potent activities on various cell lines.
Herbal Blend 2 had a more potent anti-amylase activity compared to Herbal Blend 1. The higher anti-amylase activity of Herbal Blend 2 could be due to the presence of C. verum and P. nigrum in the Herbal blend. Both of these ingredients are known to possess anti-amylase properties. For example, cinnamon extract has been reported to inhibit α-amylase, an enzyme involved in carbohydrate digestion, and reduce the postprandial glucose response64. Additionally, P. nigrum contains piperine, which has been shown to inhibit α-amylase and reduce starch digestion65. Therefore, the combination of C. verum and P. nigrum in Herbal Blend 2 may be responsible for its higher anti-amylase activity.
Herbal Blend 1 and Herbal Blend 2, revealed that they had a negligible effect on lipase enzyme activity. The reason for this could be due to the absence of specific ingredients in both Herbal blends that are known to have lipase-inhibitory properties. For example, some studies have shown that polyphenols, such as epigallocatechin-3-gallate (EGCG) found in green tea (C. sinensis) and curcuminoids found in turmeric (C. longa ), can inhibit pancreatic lipase activity66. However, the levels of these polyphenols in Herbal Blend 1 and Herbal Blend 2 may not have been sufficient to have a significant impact on lipase enzyme activity.
Figure 4 displays the percentage of inhibition at different concentrations of the tested Herbal blends on α-amylase, and the results were promising for both Herbal blends compared to the control Acarbose. Herbal Blend 2 demonstrated a percentage of inhibition of 59% at a concentration of 510 µg/mL, while Herbal Blend 1 showed 44% inhibition at the same concentration. In comparison, the percentage of inhibition for Acarbose was 64%. At a concentration of 730 µg/mL, both Herbal blends showed similar percentages of inhibition, as Herbal Blend 2 demonstrating a 60% inhibition and Herbal Blend 1 showing 58% of inhibition, while the percentage of inhibition for Acarbose was 67%. These results indicate that both Herbal blends have anti-diabetic activity through their inhibition of α-amylase, and Herbal Blend 2 was found to have slightly more potent activity compared to Herbal Blend 1.
Figure 5 presents the percentage of inhibition at different concentrations of the two tested Herbal blends against lipase. The results showed negligible effects for both Herbal blends compared to Orlistat. At a concentration of 510 µg/mL, Herbal Blend 2 had almost the same percentage of inhibition as Herbal Blend 1, with Herbal Blend 2 showing a percentage of 35% and Herbal Blend 1 showing 37%, while Orlistat exhibited a percentage of 97%. Similarly, at a concentration of 730 µg/mL, Herbal Blend 2 showed a percentage of 44%, and Herbal Blend 1 showed 42%, while Orlistat exhibited a percentage of 99%. These results suggest that the two tested Herbal blends have a negligible effect on lipase activity compared to Orlistat.
Further standardization of the active components in the investigated herbal blends, along with in vivo and preclinical research, is necessary to validate the findings of our study and develop appropriate pharmaceutical dosages from these traditional blends to enhance community healthcare.
Conclusion
In conclusion, our study provides valuable insight into the potential use of these plant Herbal blends for their anti-obesity and other health benefits. While we found that these plants have a moderate effect as anti-obesity agents, our research demonstrated potent anticancer, antioxidant, and antifibrotic effects. This presents a unique challenge, as many anticancer plants are known to have cytotoxic effects on the body. Therefore, we strongly recommend that any use of these plant Herbal blends and plants, in general, should be under the supervision of a qualified plant specialist and the Palestinian health authorities. It is essential to exercise caution when using natural remedies, and we urge individuals to seek medical advice before incorporating them into their health regimens.
Data availability
The data sets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
References
Jaradat, N. A. et al. Ethnopharmacological survey of medicinal plants practiced by traditional healers and herbalists for treatment of some urological diseases in the West Bank/Palestine. BMC Complement. Altern. Med. 17, 1–18 (2017).
Jaradat, N. A., Al-Ramahi, R., Zaid, A. N., Ayesh, O. I. & Eid, A. M. Ethnopharmacological survey of herbal remedies used for treatment of various types of cancer and their methods of preparations in the West Bank-Palestine. BMC Complement. Altern. Med. 16(1), 1–12 (2016).
Hawash, M. et al. Evaluation of the hypoglycemic effect of seven wild folkloric edible plants from Palestine: (Antidiabetic effect of seven plants from Palestine). J. Complement. Integrat. Med. 17(1), 20190032 (2019).
Hales, C. M., Carroll, M. D., Fryar, C. D., Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. 2017.
WHO. Obesity and overweight. World Health Organization. (2021).
Mosleh, R., Abd Aziz, N., Ali, S., Manan, M. & Zyoud, S. E. Drug utilization pattern and predictors of costs among patients with type II diabetes in Palestine. Pal. Med. Pharm. J. 2(2), 5 (2017).
Frankowski, R. et al. Type 2 diabetes mellitus, non-alcoholic fatty liver disease, and metabolic repercussions: The vicious cycle and its interplay with inflammation. Int. J. Mol. Sci. 24(11), 9677 (2023).
Association AD. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021 [cited 2023 17 February]. (2021). Available from: https://diabetesjournals.org/care/article/44/Supplement_1/S15/30859/2-Classification-and-Diagnosis-of-Diabetes.
Yuen, L. et al. Projections of the prevalence of hyperglycaemia in pregnancy in 2019 and beyond: Results from the international diabetes federation diabetes atlas. Diabetes Res. Clin. Pract. 157, 107841 (2019).
Troeger, J. S. et al. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 143(4), 1073–1083 (2012).
Wang, J. N. et al. Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis. Gene. 674, 57–69 (2018).
Dias, V., Junn, E. & Mouradian, M. M. The role of oxidative stress in Parkinson’s disease. J. Parkinsons Dis. 3(4), 461–491 (2013).
Lee, J. G. et al. The neuroprotective effects of melatonin: Possible role in the pathophysiology of neuropsychiatric disease. Brain Sci. 9(10), 285 (2019).
Nazzal, D., Mustafa, D., Halabi, E., Gnimat, S. & Gayada, S. Evaluation of types, stages and treatment of breast cancer among Palestinian women. Pal. Med. Pharm. J. 5(1), 35–40 (2019).
Ali-Shtayeh, M. S., Jamous, R. M. & Jamous, R. M. Herbal preparation use by patients suffering from cancer in Palestine. Complement. Therap. Clin. Pract. 17(4), 235–240 (2011).
Ali-Shtayeh, M. S., Yaniv, Z. & Mahajna, J. Ethnobotanical survey in the Palestinian area: A classification of the healing potential of medicinal plants. J. Ethnopharmacol. 73(1–2), 221–232 (2000).
Janamian, T., Myers, S. P., O’Rourke, P. & Eastwood, H. Responding to GPs’ information resource needs: Implementation and evaluation of a complementary medicines information resource in Queensland general practice. BMC Complement. Alternat. Med. 11, 1–12 (2011).
Olas, B. Carbon monoxide is not always a poison gas for human organism: Physiological and pharmacological features of CO. Chemico-Biol. Interact. 222, 37–43 (2014).
Shan, B., Cai, Y. Z., Sun, M. & Corke, H. Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents. J. Agric. Food Chem. 53(20), 7749–7759 (2005).
Padmaja, S. & Raju, T. Antioxidant effect of curcumin in selenium induced cataract of Wistar rats. (2004).
Yao, Q. Y. et al. Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats. BMC Complement. Alternat. Med. 12, 1–11 (2012).
You, W. C. et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J. Natl. Cancer Instit. 98(14), 974–83 (2006).
Wu, A. H. et al. Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal womengreen tea, controlled intervention study, hormones, lipids, glucose. Cancer Prevent. Res. 5(3), 393–402 (2012).
Cabrera, C., Artacho, R. & Giménez, R. Beneficial effects of green tea—a review. J. Am. College Nutrit. 25(2), 79–99 (2006).
Khan, N. & Mukhtar, H. Tea and health: studies in humans. Curr. Pharm. Des. 19(34), 6141–6147 (2013).
Habib, S. H. M. et al. Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics 63(6), 807–813 (2008).
Mozaffari-Khosravi, H., Talaei, B., Jalali, B. A., Najarzadeh, A. & Mozayan, M. R. The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Complement. Therap. Med. 22(1), 9–16 (2014).
Nikkhah Bodagh, M., Maleki, I. & Hekmatdoost, A. Ginger in gastrointestinal disorders: A systematic review of clinical trials. Food Sci. Nutrit. 7(1), 96–108 (2019).
Kim, E. C. et al. [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun. 335(2), 300–308 (2005).
Jagetia, G. C. & Aggarwal, B. B. “Spicing up” of the immune system by curcumin. J. Clin. Immunol. 27, 19–35 (2007).
Thakur, M., Khedkar, R., Singh, K. & Sharma, V. Ethnopharmacology of botanical galactagogues and comprehensive analysis of gaps between traditional and scientific evidence. Curr. Res. Nutrit. Food Sci. J. 11(2) (2023).
Toomari, E., Hajian, S., Mojab, F., Omidkhah, T. & Nasiri, M. Evaluation the effect of Silybum marianum ointment on episiotomy wound healing and pain intensity in primiparous women: A randomized triple blind clinical trial. BMC Complement. Med. Therap. 21, 1–11 (2021).
Derosa, G., Maffioli, P. & Sahebkar, A. Piperine and its role in chronic diseases. Anti-inflammat. Nutraceut. Chronic Dis. 173–84 (2016).
Kalaba, V., Balaban, Ž. M. & Kalaba, D. Antibacterial activity of domestic apple cider vinegar. AGROFOR. 4(1) (2019).
Hu, Q. et al. On the value of apricot kernel in modern medicine and its future development. Pak. J. Bot. 55(2), 649–655 (2023).
Guo, Z. et al. Microwave-assisted extraction of effective constituents from a Chinese herbal medicine Radix puerariae. Analytica chimica acta 436(1), 41–47 (2001).
Hawash, M. et al. In vitro and in vivo assessment of the antioxidant potential of isoxazole derivatives. Sci. Rep. 12(1), 18223 (2022).
Eid, A., Jaradat, N., Issa, L., Khraiwesh, E. & Yaish, Z. Qualitative analysis of the antioxidant, carbohydrates, and lipids enzymes inhibitory effects of Coriandrum sativum seeds; a member of Palestinian flora. Palestinian Med. Pharm. J. 8(2), 11 (2023).
Hawash, M. et al. Molecular docking, chemo-informatic properties, alpha-amylase, and lipase inhibition studies of benzodioxol derivatives. BMC Chem. 15(1), 1–10 (2021).
Eid, A. M. & Hawash, M. Biological evaluation of Safrole oil and Safrole oil Nanoemulgel as antioxidant, antidiabetic, antibacterial, antifungal and anticancer. BMC Complement. Med. Therap. 21(1), 159 (2021).
Hawash, M. et al. Evaluation of the hypoglycemic effect of seven wild folkloric edible plants from Palestine. J. Complement. Integrat. Med. 17(1) (2020).
Jaradat, N. et al. Chromatography analysis, in light of vitro antioxidant, antidiabetic, antiobesity, anti-inflammatory, antimicrobial, anticancer, and three-dimensional cancer spheroids’ formation blocking activities of Laurus nobilis aromatic oil from Palestine. Chem. Biol. Technol. Agric. 10(1), 25 (2023).
Hawash, M. et al. Synthesis, chemo-informatics, and anticancer evaluation of fluorophenyl-isoxazole derivatives. Open Chem. 19(1), 855–863 (2021).
Chang, H. H. et al. A system for reporting and evaluating adverse drug reactions of herbal medicine in Taiwan from 1998 to 2016. Sci. Rep. 11(1), 21476 (2021).
Jaradat, N. & Adawi, D. Use of herbal medicines during pregnancy in a group of Palestinian women. J. Ethnopharmacol. 150(1), 79–84 (2013).
Kocaadam, B. & Şanlier, N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Critic. Rev. Food Sci. Nutrit. 57(13), 2889–2895 (2017).
Gorinstein, S. et al. Comparison of the main bioactive compounds and antioxidant activities in garlic and white and red onions after treatment protocols. J. Agric. Food Chem. 56(12), 4418–4426 (2008).
Nahak, G. & Sahu, R. Phytochemical evaluation and antioxidant activity of Piper cubeba and Piper nigrum. J. Appl. Pharm. Sci. 153–7 (2011).
Jaradat, N. et al. Chemical constituents, antioxidant, cyclooxygenase inhibitor, and cytotoxic activities of Teucrium pruinosum boiss. Essential oil. BioMed Res. Int. (2018).
Elmarzugi, N., Amara, R., Eshmela, M. & Eid, A. An overview of nanocapsule and lipid nanocapsule: Recent developments and future prospects. Palestinian Med. Pharm. J. 8(3), 2 (2023).
Catanzaro, E., Canistro, D., Pellicioni, V., Vivarelli, F. & Fimognari, C. Anticancer potential of allicin: A review. Pharmacol. Res. 177, 106118 (2022).
Menniti-Ippolito, F. et al. Turmeric (Curcuma longa L.) food supplements and hepatotoxicity: An integrated evaluation approach. Annali dell’Istituto Superiore di Sanità 56(4), 462–9 (2020).
Turrini, E., Sestili, P. & Fimognari, C. Overview of the anticancer potential of the “king of spices” piper nigrum and its main constituent piperine. Toxins 12(12), 747 (2020).
Larasati, Y. A. & Meiyanto, E. Revealing the potency of cinnamon as an anti-cancer and chemopreventive agent. Indonesian J. Cancer Chemoprevent. 9(1), 47–62 (2018).
Sadeghi, S. et al. Anti-cancer effects of cinnamon: Insights into its apoptosis effects. European J. Med. Chem. 178, 131–140 (2019).
Caserta, S., Genovese, C., Cicero, N., Gangemi, S. & Allegra, A. The anti-cancer effect of cinnamon aqueous extract: A focus on hematological malignancies. Life 13(5), 1176 (2023).
Singh, K. et al. Impact of green extraction on curcuminoid content, antioxidant activities and anti-cancer efficiency (in vitro) from turmeric rhizomes (Curcuma longa L.). Foods 11(22), 3633 (2022).
Zhou, J. L. et al. Chemical markers’ knockout coupled with UHPLC-HRMS-based metabolomics reveals anti-cancer integration effects of the curcuminoids of turmeric (Curcuma longa L.) on lung cancer cell line. J. Pharm. Biomed. Anal. 175, 112738 (2019).
Johnson, J. J. & Mukhtar, H. Curcumin for chemoprevention of colon cancer. Cancer letters. 255(2), 170–181 (2007).
Hamidpour, R., Hamidpour, S., Hamidpour, M., Sohraby, M. & Hamidpour, M. Turmeric (Curcuma longa): From a variety of traditional medicinal applications to its novel roles as active antioxidant, anti-inflammatory, anti-cancer, and anti-diabetes. Int. J. Pharmacol. Phytochem. Ethnomed. 1(1), 37–45 (2015).
Yang, Y. S. et al. Lipid-lowering effects of curcumin in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled trial. Phytotherap. Res. 28(12), 1770–1777 (2014).
Roehlen, N., Crouchet, E. & Baumert, T. F. Liver fibrosis: Mechanistic concepts and therapeutic perspectives. Cells 9(4), 875 (2020).
Milito, A., Brancaccio, M., D’Argenio, G. & Castellano, I. Natural sulfur-containing compounds: An alternative therapeutic strategy against liver fibrosis. Cells 8(11), 1356 (2019).
Beejmohun, V. et al. Acute effect of Ceylon cinnamon extract on postprandial glycemia: alpha-amylase inhibition, starch tolerance test in rats, and randomized crossover clinical trial in healthy volunteers. BMC Complement. Alternat. Med. 14, 1–11 (2014).
Magaña-Barajas, E. et al. In vitro α-amylase and α-glucosidase enzyme inhibition and antioxidant activity by capsaicin and piperine from Capsicum chinense and Piper nigrum fruits. J. Environ. Sci. Health B. 56(3), 282–91 (2021).
Meydani, M. & Hasan, S. T. Dietary polyphenols and obesity. Nutrients. 2(7), 737–751 (2010).
Acknowledgements
The author(s) would like to thank An-Najah National University (www.najah.edu) for the technical support provided to publish the present manuscript.
Author information
Authors and Affiliations
Contributions
M.H: Conceptualization; Data curation; Formal analysis; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Writing—original draft; Writing—review & editing. N.J.: Data curation; Formal analysis; Investigation; Methodology; Resources; Supervision; Validation; Visualization; Writing—review & editing. N.A.S.: Methodology; Investigation; and Data curation. B.S.: Methodology; Investigation; and Data curation. A.A.A.: Methodology; Investigation; and Data curation. Y.H.H.: Investigation; Validation; Writing—review & editing. All authors reviewed the paper and read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hawash, M., Jaradat, N., Salhi, N.A. et al. Assessing the therapeutic potential and safety of traditional anti-obesity herbal blends in Palestine. Sci Rep 14, 1919 (2024). https://doi.org/10.1038/s41598-024-52172-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-52172-7
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.